Table 4.
Thirty-day outcome after COVID-19 diagnosis in early and late in cohorts.
| MS cohorta | Non-MS cohorta | |||||
|---|---|---|---|---|---|---|
| Early cohort (n=371) | Late cohort (n=472) | OR (95% CI) | Early cohort (n=636) | Late cohort (n=1050) | OR (95% CI) | |
| Hospitalization | 143 (38.5) | 197 (41.7) | 1.14 (0.85–1.91) | 209 (32.8) | 351 (33.4) | 1.01 (0.83–1.27) |
| ICU admission | 52 (14.0) | 35 (7.4) | 0.49 (0.31–0.77) | 85 (13.7) | 74 (7.0) | 0.49 (0.35–0.68) |
| Mechanical ventilation | 34 (9.2) | 25 (4.8) | 0.51 (0.29–0.88) | 65 (10.2) | 65 (6.2) | 0.58 (0.41–0.83) |
| Death | 40 (10.8) | 16 (3.4) | 0.30 (0.16–0.53) | 51 (8.0) | 25 (2.4) | 0.28 (0.17–0.45) |
| Composite outcomeb | 62 (16.7) | 46 (9.7) | 0.45 (0.30–0.67) | 181 (15.8) | 93 (8.8) | 0.52 (0.38–0.70) |
Abbreviations: CI, confidence interval; COVID-19, corona virus disease 2019; ICU, intensive care unit; MS, multiple sclerosis; n, number; OR, odds ratio.
a
Data are presented as number (percentage) of subjects, unless otherwise indicated.
b
ICU admission, mechanical ventilation, and/or death.